Melinta Therapeutics announced is joining with more than 150 other major food companies, retailers, and human and animal health stakeholders at the White House Forum on Antibiotic Stewardship to commit to implementing changes over the next five years to slow the emergence of antibiotic-resistant bacteria, detect resistant strains, preserve the efficacy of our existing antibiotics, and prevent the spread of resistant infections.

“We are pleased to be participating in this effort to combat antibiotic resistance,” said Eugene Sun, MD, Melinta’s Executive Vice President, Research and Development. “A multi-pronged approach is required to keep up with the relentless evolution of resistance.”